 | Up a level |
Li, Huayi and Peng, Zikun and Zhu, Jianqing and Zhao, Weidong and Huang, Yi and An, Ruifang and Zheng, Hong and Qu, Pengpeng and Wang, Li and Zhou, Qi and Wang, Danbo and Lou, Ge and Wang, Jing and Wang, Ke and Kong, Beihua and Xie, Xing and Yin, Rutie and Low, John and Rozita, Abdul Malik and Sen, Lim Chun and Meng, Yong Chee and Kiong, Kho Swee and Liu, Jihong and Liang, Zhiqing and Lv, Weiguo and Zhu, Yaping and Hu, Weiguo and Sun, Wei and Su, Jingya and Wang, Qiqi and Zang, Rongyu and Ma, Ding and Gao, Qinglei (2024) Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer. BMC Medicine, 22 (1). p. 199. ISSN 1741-7015, DOI https://doi.org/10.1186/s12916-024-03409-9.
Gao, Qinglei and Zhu, Jianqing and Zhao, Weidong and Huang, Yi and An, Ruifang and Zheng, Hong and Qu, Pengpeng and Wang, Li and Zhou, Qi and Wang, Danbo and Lou, Ge and Wang, Jing and Wang, Ke and Low, John and Kong, Beihua and Abdul Malik, Rozita and Sen, Lim Chun and Yin, Rutie and Xie, Xing and Liu, Jihong and Sun, Wei and Su, Jingya and Zhang, Chunyi and Zang, Rongyu and Ma, Ding (2022) Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA). Clinical Cancer Research, 28 (11). pp. 2278-2285. ISSN 1078-0432, DOI https://doi.org/10.1158/1078-0432.CCR-21-3023.
Yoon, Sook-Yee and Wong, Siu Wan and Lim, Joanna and Ahmad, Syuhada and Mariapun, Shivaani and Padmanabhan, Heamanthaa and Hassan, Nur Tiara and Lau, Shao Yan and Ch'ng, Gaik-Siew and Haniffa, Muzhirah and Ong, Winnie P. and Rethanavelu, Kavitha and Moey, Lip Hen and Keng, Wee Teik and Omar, Jamil and Mohd Abas, Mohd Norazam and Yong, Chee Meng and Ramasamy, Vickneswaren and Md Noor, Mohd Rushdan and Aliyas, Ismail and Lim, Michael C. K. and Suberamaniam, Anuradha and Mat Adenan, Noor Azmi and Ahmad, Zatul Akmar and Ho, Gwo Fuang and Abdul Malik, Rozita and Subramaniam, Suguna and Khoo, Boom Ping and Raja, Arivendran and Chin, Yeung Sing and Sim, Wee Wee and Teh, Beng Hock and Kho, Swee Kiong and Ong, Eunice S. E. and Voon, Pei Jye and Ismail, Ghazali and Lee, Chui Ling and Abdullah, Badrul Zaman and Loo, Kwong Sheng and Lim, Chun Sen and Lee, Saw Joo and Lim, Keng Joo Lim and Shafiee, Mohamad Nasir and Ismail, Fuad and Latiff, Zarina Abdul and Ismail, Mohd Pazudin and Mohamed Jamli, Mohamad Faiz and Kumarasamy, Suresh and Leong, Kin Wah and Low, John and Md Yusof, Mastura and Ahmad Mustafa, Ahmad Muzamir and Mat Ali, Nor Huda and Makanjang, Mary and Tayib, Shahila and Cheah, Nellie and Lim, Boon Kiong and Fong, Chee Kin and Foo, Yoke Ching and Mellor Abdullah, Matin and Tan, Teck Sin and Chow, Doris S. Y. and Ho, Kean Fatt and Raman, Rakesh and Radzi, Ahmad and Deniel, Azura and Teoh, Daren C. Y. and Ang, Soo Fan and Joseph, Joseph K. and Ng, Paul Hock Oon and Tho, Lye-Mun and Ahmad, Azura Rozila and Muin, Ileena and Bleiker, Eveline and George, Angela and Thong, Meow-Keong and Woo, Yin Ling and Teo, Soo Hwang (2022) Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes. Journal of Medical Genetics, 59 (3). pp. 220-229. ISSN 0022-2593, DOI https://doi.org/10.1136/jmedgenet-2020-107416.
